oseltamivir phosphate for oral suspension

oseltamivir phosphate for oral suspension
SPL v5
SPL
SPL Set ID 7c0923ad-80b0-4134-b44a-754ea599f356
Route
oral
Published
Effective Date 2024-07-30
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
oseltamivir acid (6 mg)
Inactive Ingredients
monosodium citrate saccharin sodium sodium benzoate sorbitol titanium dioxide water xanthan gum

Identifiers & Packaging

Pill Appearance
Color: white
Marketing Status
anda active Since 2021-08-05

Description

NDC 70771-1598-6 Oseltamivir Phosphate for Oral Suspension 6 mg/mL * 60 mL (usable volume after constitution)


Medication Information

Description

NDC 70771-1598-6 Oseltamivir Phosphate for Oral Suspension 6 mg/mL * 60 mL (usable volume after constitution)

Package Label.principal Display Panel

NDC 70771-1598-6

Oseltamivir Phosphate for Oral Suspension

6 mg/mL *

60 mL (usable volume after constitution)


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1598-6

Oseltamivir Phosphate for Oral Suspension

6 mg/mL *

60 mL (usable volume after constitution)


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)